Clincosm LogoSign in Get a demo

stage ii breast cancer

Showing 1 - 25 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Recruiting
  • Breast Cancer Female
  • +4 more
    • Ho Chi Minh City, Vietnam
    • +1 more
    Oct 16, 2023

    Prepectoral and Subpectoral Breast Reconstruction

    Recruiting
    • Stage II Breast Cancer
    • Stage I Breast Cancer
    • The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital medical University
    Apr 16, 2023

    Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

    Active, not recruiting
    Has Results
    • Estrogen Receptor Negative
    • +11 more
    • Mobile, Alabama
    • +1023 more
    Dec 7, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +15 more
    • Bellevue, Nebraska
    • +3 more
    Nov 30, 2022

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

    Terminated
    • Estrogen Receptor Positive
    • +16 more
    • Biopsy of Breast
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

    Recruiting
    • Early-stage Breast Cancer
    • +6 more
    • Fullerton, California
    • +8 more
    Sep 19, 2022

    Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • THRIVE
    • Health Education Support Program
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 8, 2022

    Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +9 more
    • Boston, Massachusetts
    • +1 more
    Sep 9, 2022

    Stage I Breast Cancer, Stage I Colorectal Cancer AJCC v6 and v7, Stage I Prostate Cancer Trial in New Brunswick, Philadelphia

    Completed
    • Stage I Breast Cancer
    • +18 more
    • Informational Intervention
    • +4 more
    • New Brunswick, New Jersey
    • +1 more
    Aug 23, 2022

    Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in United States (Exercise)

    Recruiting
    • Breast Cancer
    • +11 more
    • Exercise
    • San Carlos, California
    • +7 more
    Aug 24, 2022

    Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

    Recruiting
    • Breast Cancer
    • +7 more
    • Dendritic Cell Vaccine (DC1)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 23, 2022

    Breast Cancer, Breast Cancer Female, DCIS Trial in Stony Brook (Partial Chest Wall Radiation Therapy)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Partial Chest Wall Radiation Therapy
    • Stony Brook, New York
      Stony Brook Cancer Center
    Jun 23, 2022

    Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Washington, Baltimore (Simvastatin,

    Active, not recruiting
    Has Results
    • Breast Cancer
    • +3 more
    • Washington, District of Columbia
    • +1 more
    May 19, 2022

    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

    Terminated
    Has Results
    • Estrogen Receptor-negative Breast Cancer
    • +6 more
    • Baltimore, Maryland
      University of Maryland Baltimore
    Apr 29, 2022

    HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

    Active, not recruiting
    Has Results
    • HER-2 Positive Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +3 more
    Mar 4, 2022

    Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in Aurora (Exemestane, Exemestane and tamoxifen)

    Completed
    Has Results
    • Breast Cancer
    • +2 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Feb 22, 2022

    Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

    Active, not recruiting
    • Inflammatory Breast Cancer
    • +9 more
    • External beam radiation therapy
    • New Brunswick, New Jersey
    • +1 more
    Jan 30, 2022

    Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)

    Active, not recruiting
    • Stage IA Breast Cancer
    • +6 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jan 14, 2022

    Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Worldwide (TX05 (trastuzumab), Herceptin®, Paclitaxel)

    Completed
    Has Results
    • Breast Cancer
    • +4 more
    • TX05 (trastuzumab)
    • +4 more
    • Lesnoy, Minsk Region, Belarus
    • +145 more
    Jan 7, 2022

    HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

    Active, not recruiting
    • HER2/Neu Negative
    • +10 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Seattle, Washington
    • +1 more
    Jan 11, 2022

    Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering

    Terminated
    • Healthy, no Evidence of Disease
    • +4 more
    • light-scattering spectroscopy
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Nov 11, 2021

    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

    Active, not recruiting
    • BRCA1 Mutation Carrier
    • +8 more
    • soy isoflavones
    • +7 more
    • Los Angeles, California
      University of Southern California
    Nov 11, 2021

    Breast Tumor Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in L'Hospitalet De Llobregat (Denosumab 120 MG/1.7 ML

    Active, not recruiting
    • Breast Neoplasm Female
    • +4 more
    • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
    • L'Hospitalet De Llobregat, Barcelona, Spain
      Institut Català d'Oncologia - L'Hospitalet
    Nov 2, 2021

    Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,

    Completed
    • Breast Cancer Female
    • +6 more
    • Breast reconstruction decision aid
    • Educational website
    • Austin, Texas
      Texas Oncology
    Nov 1, 2021